ALS Therapy Development Institute

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Targeting of endoplasmic reticulum dysfunction and protein folding...
- Patent number 12,157,728
- Issue date Dec 3, 2024
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Copper complexes for treatment of neurodegenerative disorders
- Patent number 12,012,422
- Issue date Jun 18, 2024
- ALS Therapy Development Institute
- Matvey Lukashev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of dipeptide repeat proteins
- Patent number 11,857,534
- Issue date Jan 2, 2024
- ALS Therapy Development Institute
- Fernando G. Vieira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of endoplasmic reticulum dysfunction and protein folding...
- Patent number 11,708,349
- Issue date Jul 25, 2023
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies and methods for treating CD40L-related diseas...
- Patent number 11,692,040
- Issue date Jul 4, 2023
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Copper complexes for treatment of neurodegenerative disorders
- Patent number 11,660,324
- Issue date May 30, 2023
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of dipeptide repeat proteins
- Patent number 11,607,402
- Issue date Mar 21, 2023
- ALS Therapy Development Institute
- Fernando G. Vieira
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic anti-CD40 ligand antibodies
- Patent number 11,384,152
- Issue date Jul 12, 2022
- ALS Therapy Development Institute
- Alexey Lugovskoy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD40L antibodies
- Patent number 11,014,990
- Issue date May 25, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a CD40L associated disease or disorder by admin...
- Patent number 10,683,356
- Issue date Jun 16, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40L antibodies
- Patent number 10,106,618
- Issue date Oct 23, 2018
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 9,044,459
- Issue date Jun 2, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
- Patent number 8,946,301
- Issue date Feb 3, 2015
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
- Patent number 8,673,308
- Issue date Mar 18, 2014
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of neurodegenerative diseases
- Patent number 8,435,514
- Issue date May 7, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240368195
- Publication date Nov 7, 2024
- ALS Therapy Development Institute
- Matvey Lukashev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20240043549
- Publication date Feb 8, 2024
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20240016879
- Publication date Jan 18, 2024
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...
- Publication number 20230382890
- Publication date Nov 30, 2023
- ALS Therapy Development Institute
- Alan GILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20230054997
- Publication date Feb 23, 2023
- ALS Therapy Development Institute
- Matvey Lukashev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC ANTI-CD40 LIGAND ANTIBODIES
- Publication number 20230048260
- Publication date Feb 16, 2023
- ALS Therapy Development Institute
- Alexey Lugovskoy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF DIPEPTIDE REPEAT PROTEINS
- Publication number 20220142974
- Publication date May 12, 2022
- ALS Therapy Development Institute
- Fernando G. VIEIRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20210269538
- Publication date Sep 2, 2021
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20210038676
- Publication date Feb 11, 2021
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...
- Publication number 20210009558
- Publication date Jan 14, 2021
- ALS Therapy Development Institute
- Alan GILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF DIPEPTIDE REPEAT PROTEINS
- Publication number 20200405689
- Publication date Dec 31, 2020
- ALS Therapy Development Institute
- Fernando G. VIEIRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20200277391
- Publication date Sep 3, 2020
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Anti-CD40 Ligand Antibodies
- Publication number 20200223932
- Publication date Jul 16, 2020
- ALS Therapy Development Institute
- Alexey Lugovskoy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20190092868
- Publication date Mar 28, 2019
- ALS Therapy Development Institute
- John M. Lincecum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...
- Publication number 20170342158
- Publication date Nov 30, 2017
- ALS Therapy Development Institute
- John M. Lincecum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Measurement Of ALS Progression Based On Kinetic Data
- Publication number 20170231558
- Publication date Aug 17, 2017
- ALS Therapy Development Institute
- Alan Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
- Publication number 20130150454
- Publication date Jun 13, 2013
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES
- Publication number 20120237505
- Publication date Sep 20, 2012
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for the Treatment of Neurodegenerative Diseases
- Publication number 20110293612
- Publication date Dec 1, 2011
- ALS Therapy Development Institute
- Steven Perrin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
98020510 - TRI-STATE TREK
- Serial number 98020510
- Filing date May 31, 2023
- ALS Therapy Development Institute
- 25 - Clothing, footwear, headgear

ALS Therapy Development Institute

Organization

Patents Grantslast 30 patents

Targeting of endoplasmic reticulum dysfunction and protein folding...

Copper complexes for treatment of neurodegenerative disorders

Inhibition of dipeptide repeat proteins

Targeting of endoplasmic reticulum dysfunction and protein folding...

Anti-CD40L antibodies and methods for treating CD40L-related diseas...

Copper complexes for treatment of neurodegenerative disorders

Inhibition of dipeptide repeat proteins

Therapeutic anti-CD40 ligand antibodies

Anti-CD40L antibodies

Methods of treating a CD40L associated disease or disorder by admin...

Anti-CD40L antibodies

Method for the treatment of neurodegenerative diseases

Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis

Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases

Method for the treatment of neurodegenerative diseases

Patents Applicationslast 30 patents

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

THERAPEUTIC ANTI-CD40 LIGAND ANTIBODIES

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

TARGETING OF ENDOPLASMIC RETICULUM DYSFUNCTION AND PROTEIN FOLDING...

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

Therapeutic Anti-CD40 Ligand Antibodies

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEAS...

Measurement Of ALS Progression Based On Kinetic Data

TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS

TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES

Method for the Treatment of Neurodegenerative Diseases

Trademarklast 30 trademarks

98020510 - TRI-STATE TREK